These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32343625)

  • 1. Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses.
    Lim AC; Grodin EN; Green R; Venegas A; Meredith LR; Courtney KE; Moallem NR; Sayegh P; London ED; Ray LA
    Am J Drug Alcohol Abuse; 2020 Sep; 46(5):565-576. PubMed ID: 32343625
    [No Abstract]   [Full Text] [Related]  

  • 2. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder.
    Roche DJO; Worley MJ; Courtney KE; Bujarski S; London ED; Shoptaw S; Ray LA
    Psychopharmacology (Berl); 2017 Jul; 234(13):1997-2007. PubMed ID: 28357460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K
    Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder.
    Kohno M; Dennis LE; McCready H; Schwartz DL; Hoffman WF; Korthuis PT
    Drug Alcohol Depend; 2018 Nov; 192():186-192. PubMed ID: 30266003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans.
    Courtney KE; Ghahremani DG; Ray LA
    Neuropsychopharmacology; 2016 Nov; 41(12):2872-2881. PubMed ID: 27312405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of naltrexone for amfetamine and methamfetamine use disorder: a systematic review of randomized controlled trials.
    Lam L; Anand S; Li X; Tse ML; Zhao JX; Chan EW
    Clin Toxicol (Phila); 2019 Apr; 57(4):225-233. PubMed ID: 30451013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial.
    Coffin PO; Santos GM; Hern J; Vittinghoff E; Santos D; Matheson T; Colfax G; Batki SL
    Addiction; 2018 Feb; 113(2):268-278. PubMed ID: 28734107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
    Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.
    Wang ZY; Guo LK; Han X; Song R; Dong GM; Ma CM; Wu N; Li J
    Behav Brain Res; 2021 Feb; 399():112971. PubMed ID: 33075396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine.
    Marks KR; Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
    J Clin Psychopharmacol; 2016 Jun; 36(3):213-21. PubMed ID: 27043121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.
    De La Garza R; Mahoney JJ; Culbertson C; Shoptaw S; Newton TF
    Pharmacol Biochem Behav; 2008 Apr; 89(2):200-8. PubMed ID: 18207225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT-2 trial.
    Li MJ; Chau B; Belin T; Carmody T; Jha MK; Marino EN; Trivedi M; Shoptaw SJ
    Addiction; 2024 Oct; 119(10):1840-1845. PubMed ID: 38856086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial.
    Miranda R; Ray L; Blanchard A; Reynolds EK; Monti PM; Chun T; Justus A; Swift RM; Tidey J; Gwaltney CJ; Ramirez J
    Addict Biol; 2014 Sep; 19(5):941-54. PubMed ID: 23489253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence.
    Jayaram-Lindström N; Konstenius M; Eksborg S; Beck O; Hammarberg A; Franck J
    Neuropsychopharmacology; 2008 Jul; 33(8):1856-63. PubMed ID: 17957221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated stimulation of the dorsolateral-prefrontal cortex improves executive dysfunctions and craving in drug addiction: A randomized, double-blind, parallel-group study.
    Alizadehgoradel J; Nejati V; Sadeghi Movahed F; Imani S; Taherifard M; Mosayebi-Samani M; Vicario CM; Nitsche MA; Salehinejad MA
    Brain Stimul; 2020; 13(3):582-593. PubMed ID: 32289681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.
    Newton TF; Reid MS; De La Garza R; Mahoney JJ; Abad A; Condos R; Palamar J; Halkitis PN; Mojisak J; Anderson A; Li SH; Elkashef A
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1037-45. PubMed ID: 18664303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lofexidine in Combination With Oral Naltrexone for Opioid Use Disorder Relapse Prevention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study.
    Hermes G; Hyman SM; Fogelman N; Kosten TR; Sinha R
    Am J Addict; 2019 Nov; 28(6):480-488. PubMed ID: 31448846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cue reactivity and opioid blockade in amphetamine dependence: A randomized, controlled fMRI study.
    Guterstam J; Jayaram-Lindström N; Berrebi J; Petrovic P; Ingvar M; Fransson P; Franck J
    Drug Alcohol Depend; 2018 Oct; 191():91-97. PubMed ID: 30096639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.
    Comer SD; Mogali S; Saccone PA; Askalsky P; Martinez D; Walker EA; Jones JD; Vosburg SK; Cooper ZD; Roux P; Sullivan MA; Manubay JM; Rubin E; Pines A; Berkower EL; Haney M; Foltin RW
    Neuropsychopharmacology; 2013 Nov; 38(12):2427-38. PubMed ID: 23736314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
    Ahmadi J; Sahraian A; Biuseh M
    Trials; 2019 Jul; 20(1):468. PubMed ID: 31362784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.